Aarti Drugs Ltd (AARTIDRUGS) — Sustainability Report | 2 September 2026

Aarti Drugs Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26 to BSE and NSE on September 2, 2026, as mandated under SEBI Regulation 34(2)(f). The report details ESG disclosures across 26 principles, covering environmental impact, social initiatives, governance, and stakeholder engagement. It includes metrics on carbon footprint, water and waste management, employee welfare, and supply chain practices. The filing confirms standalone reporting boundary, no third-party assurance, and references its website for policies and grievance mechanisms. No financial figures beyond routine disclosures are provided.